It is expected that alterations in the expression of SLC6A4 influence the serotonergic system and several studies have shown associations with methylation levels and psychiatric disorders, including depression and post-traumatic stress disorder [15, 17–20]. Here, SLC6A4 is linked to depressive disorder.